21CEC PX PHARM LTD

Company Registration Number:
04784475 (England and Wales)

Unaudited micro entity accounts for the year ended 05 April 2025

Period of accounts

Start date: 06 April 2024

End date: 05 April 2025

21CEC PX PHARM LTD

Contents of the Financial Statements

for the Period Ended 05 April 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

21CEC PX PHARM LTD

Company Information

for the Period Ended 05 April 2025




Director: Claire Chan Bleasdale
Registered office: 45
Oaklands
Westham
Pevensey
BN24 5AW
Company Registration Number: 04784475 (England and Wales)

21CEC PX PHARM LTD

Directors' Report Period Ended 05 April 2025

The directors present their report with the financial statements of the company for the period ended 05 April 2025

Principal Activities

We had to reduce all expenses as possible. Due to the Russia-Ukraine war, Middle East war, and high inflation, this year we were still in very difficult situation.

Directors

The director(s) shown below were appointed to the company during the period
Claire Chan Bleasdale
06 April 2024

This report was approved by the board of directors on 6 April 2025
And Signed On Behalf Of The Board By:

Name: Claire Chan Bleasdale
Status: Director

21CEC PX PHARM LTD

Profit and Loss Account

for the Period Ended 05 April 2025


2025
£

2024
£
Turnover 2,621 1,135
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 1,501 ) ( 525 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 1,009 ) ( 586 )
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period 111 24

21CEC PX PHARM LTD

Balance sheet

As at 05 April 2025


2025
£

2024
£
Called up share capital not paid: 0 0
Fixed Assets: 2,114 2,114
Current assets: 14,713 11,557
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 14,713 11,557
Total assets less current liabilities: 16,827 13,671
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 16,827 13,671
Capital and reserves: 16,827 13,671

21CEC PX PHARM LTD

Balance sheet continued

For the year ending 5 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 6 April 2025
And Signed On Behalf Of The Board By:

Name: Claire Chan Bleasdale
Status: Director

The notes form part of these financial statements

21CEC PX PHARM LTD

Footnotes to the Financial Statements

for the Period Ended 05 April 2025

  • 1. Employee Information

    Average number of employees: 2

21CEC PX PHARM LTD

Footnotes to the Financial Statements

for the Period Ended 05 April 2025

  • 2. Off balance sheet disclosure

    No